New Way to Treat Common Hospital-Acquired Infection: Novel Approach May Offer Treatment for Other Bacterial Diseases, University of California, Los Angeles (UCLA) Study

Researchers at the David Geffen School of Medicine at UCLA and the University of Texas Medical Branch at Galveston have discovered a molecular process by which the body can defend against the effects of Clostridium difficile infection (CDI), pointing the way to a promising new approach for treating an intestinal disease that has become more common, more severe and harder to cure in recent years.